Tuesday, October 20, 2020
Home News Pharma News

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

Combatting resistant depression with DMT and digital therapy

Combatting resistant depression with DMT and digital therapy

A wellbeing company is developing novel formulations of dimethyltryptamine (DMT) to help combat treatment resistant depression in combination with digital psychotherapy. Nearly 264 million people live...
Opioid addiction warnings to be strengthened in UK

Opioid addiction warnings to be strengthened in UK

Regulators in the UK are strengthening opioid addiction and dependence warnings on patient information labels and leaflets. The Medicines and Healthcare products Regulatory Agency (MHRA)...
Psychedelics association to bridge medical establishment and industry gap

Psychedelics association to bridge medical establishment and industry gap

Leaders in the field of psychedelic medicine have joined forces to create the global Psychedelic Medicine Association (PMA), which aims to bridge the gap...
Ketamine therapy insights from experts in the field

Ketamine therapy insights from experts in the field

A Molecular Masterclass conference delved into the benefits, research, and policy surrounding ketamine therapy. The masterclass explored ketamine at the intersection of clinical care, research,...
Compounding pharmacies and turbulent pharmaceutical scenarios

Compounding pharmacies and turbulent pharmaceutical scenarios

Market research firm Global Market Insights explores global drug shortages and the rising adoption of customised medicine in developed regions. Compounding is one of the...
Patient distrust in pharma companies sees launch of medication Trustpilot

Patient distrust in pharma companies sees launch of medication Trustpilot

A unique medication Trustpilot has been launched to help amplify patients voices as research reveals that 93% lack trust in pharmaceutical companies. DrugsDisclosed.com has been launched...
Study shows metyrapone effective for treating rare Cushing’s Syndrome

Study shows metyrapone effective for treating rare Cushing’s Syndrome

The first ever prospective study to test the safety and efficacy of metyrapone in patients with Cushing’s Syndrome in a real-life setting has shown...
Could COVID-19 lead to an increase in antimicrobial resistance?

Could COVID-19 lead to an increase in antimicrobial resistance?

According to a new study, the use of antibiotics in the treatment of COVID-19 could lead to an increase in antimicrobial resistance (AMR) among...
The Ketamine Conference: a molecular masterclass

The Ketamine Conference: A Molecular Masterclass

The Ketamine Conference: A Molecular Masterclass is set to take place today, featuring a host of experts in the delivery of ketamine therapy for...
European Commission reaches agreement on potential COVID-19 vaccine

European Commission reaches agreement on potential COVID-19 vaccine

Today, the European Commission has reached a first agreement with the pharmaceutical company AstraZeneca to purchase a potential vaccine against COVID-19. Once the vaccine has...
First at-home treatment for spinal muscular atrophy approved by FDA

First at-home treatment for spinal muscular atrophy approved by FDA

The first at-home, orally administered treatment for spinal muscular atrophy has been approved by the US Food and Drug Administration (FDA). The treatment – Evrysdi...
New way to increase antimicrobial sensitivity discovered

New way to increase antimicrobial sensitivity discovered

Scientists have discovered a new way to make bacteria more sensitive to antibiotics in a bid to tackle the antibiotic resistance crisis. In a new...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest